The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

NCT06217848 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Panhypopituitarism
Craniopharyngioma
Hypothalamic Obesity

Interventions

DRUG: Saxenda

Sponsor

Seoul National University Hospital